These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1660525)

  • 1. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity.
    Peppel K; Crawford D; Beutler B
    J Exp Med; 1991 Dec; 174(6):1483-9. PubMed ID: 1660525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity.
    Loetscher H; Gentz R; Zulauf M; Lustig A; Tabuchi H; Schlaeger EJ; Brockhaus M; Gallati H; Manneberg M; Lesslauer W
    J Biol Chem; 1991 Sep; 266(27):18324-9. PubMed ID: 1655744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins.
    Scallon BJ; Trinh H; Nedelman M; Brennan FM; Feldmann M; Ghrayeb J
    Cytokine; 1995 Nov; 7(8):759-70. PubMed ID: 8664442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.
    Wright A; Morrison SL
    J Exp Med; 1994 Sep; 180(3):1087-96. PubMed ID: 8064227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF action.
    Berger V; Richter F; Zettlitz K; Unverdorben F; Scheurich P; Herrmann A; Pfizenmaier K; Kontermann RE
    Protein Eng Des Sel; 2013 Oct; 26(10):581-7. PubMed ID: 24006371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a TNF inhibitor in transgenic mice.
    Peppel K; Poltorak A; Melhado I; Jirik F; Beutler B
    J Immunol; 1993 Nov; 151(10):5699-703. PubMed ID: 7693816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and expression of a mouse-human chimeric antibody against human tumor necrosis factor-alpha.
    Nagahira K; Fukuda Y; Nasu T; Kawashima H; Noguchi C; Kurihara T; Oikawa S; Nakanishi T
    Immunol Lett; 1998 Dec; 64(2-3):139-44. PubMed ID: 9870665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.
    Ashkenazi A; Marsters SA; Capon DJ; Chamow SM; Figari IS; Pennica D; Goeddel DV; Palladino MA; Smith DH
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10535-9. PubMed ID: 1660140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody.
    Haak-Frendscho M; Marsters SA; Mordenti J; Brady S; Gillett NA; Chen SA; Ashkenazi A
    J Immunol; 1994 Feb; 152(3):1347-53. PubMed ID: 8301136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation.
    Howard OM; Clouse KA; Smith C; Goodwin RG; Farrar WL
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2335-9. PubMed ID: 7681592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection with a brain-penetrating biologic tumor necrosis factor inhibitor.
    Zhou QH; Sumbria R; Hui EK; Lu JZ; Boado RJ; Pardridge WM
    J Pharmacol Exp Ther; 2011 Nov; 339(2):618-23. PubMed ID: 21831964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein.
    Himmler A; Maurer-Fogy I; Krönke M; Scheurich P; Pfizenmaier K; Lantz M; Olsson I; Hauptmann R; Stratowa C; Adolf GR
    DNA Cell Biol; 1990 Dec; 9(10):705-15. PubMed ID: 1702293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
    Browning JL; Dougas I; Ngam-ek A; Bourdon PR; Ehrenfels BN; Miatkowski K; Zafari M; Yampaglia AM; Lawton P; Meier W
    J Immunol; 1995 Jan; 154(1):33-46. PubMed ID: 7995952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cysteine-rich domains of the type 1 tumor necrosis factor receptor involved in ligand binding.
    Marsters SA; Frutkin AD; Simpson NJ; Fendly BM; Ashkenazi A
    J Biol Chem; 1992 Mar; 267(9):5747-50. PubMed ID: 1313418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of lymphotoxin (LT alpha) and a soluble dimeric form of its receptor using the baculovirus expression system.
    Crowe PD; VanArsdale TL; Walter BN; Dahms KM; Ware CF
    J Immunol Methods; 1994 Jan; 168(1):79-89. PubMed ID: 8288897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides.
    Qin W; Feng J; Li Y; Lin Z; Shen B
    Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
    Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
    Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.
    Kohno T; Brewer MT; Baker SL; Schwartz PE; King MW; Hale KK; Squires CH; Thompson RC; Vannice JL
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8331-5. PubMed ID: 2172983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.
    Estrov Z; Kurzrock R; Pocsik E; Pathak S; Kantarjian HM; Zipf TF; Harris D; Talpaz M; Aggarwal BB
    J Exp Med; 1993 Mar; 177(3):763-74. PubMed ID: 8382256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.